148 related articles for article (PubMed ID: 11320407)
1. Direct transfection and activation of human cutaneous dendritic cells.
Larregina AT; Watkins SC; Erdos G; Spencer LA; Storkus WJ; Beer Stolz D; Falo LD
Gene Ther; 2001 Apr; 8(8):608-17. PubMed ID: 11320407
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of CD8+CTL responses following gene gun immunization targeting the skin with intracutaneous injection of antigen-transduced dendritic cells.
Gaffal E; Schweichel D; Tormo D; Steitz J; Lenz J; Basner-Tschakarjan E; Limmer A; Tüting T
Eur J Cell Biol; 2007 Dec; 86(11-12):817-26. PubMed ID: 16928407
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
[TBL] [Abstract][Full Text] [Related]
4. Human dendritic cells genetically engineered to express a melanoma polyepitope DNA vaccine induce multiple cytotoxic T-cell responses.
Smith SG; Patel PM; Porte J; Selby PJ; Jackson AM
Clin Cancer Res; 2001 Dec; 7(12):4253-61. PubMed ID: 11751527
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells.
Bontkes HJ; Kramer D; Ruizendaal JJ; Kueter EW; van Tendeloo VF; Meijer CJ; Hooijberg E
Gene Ther; 2007 Feb; 14(4):366-75. PubMed ID: 17036057
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.
Ueno H; Tcherepanova I; Reygrobellet O; Laughner E; Ventura C; Palucka AK; Banchereau J
J Immunol Methods; 2004 Feb; 285(2):171-80. PubMed ID: 14980432
[TBL] [Abstract][Full Text] [Related]
7. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH
Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
Stronen E; Abrahamsen IW; Gaudernack G; Wälchli S; Munthe E; Buus S; Johansen FE; Lund-Johansen F; Olweus J
Scand J Immunol; 2009 Apr; 69(4):319-28. PubMed ID: 19284496
[TBL] [Abstract][Full Text] [Related]
9. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Loskog A; Tötterman TH; Böhle A; Brandau S
Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
[TBL] [Abstract][Full Text] [Related]
10. Thermal regulation of dendritic cell activation and migration from skin explants.
Ostberg JR; Kabingu E; Repasky EA
Int J Hyperthermia; 2003; 19(5):520-33. PubMed ID: 12944167
[TBL] [Abstract][Full Text] [Related]
11. Development of a Langerhans cell-targeted gene therapy format using a dendritic cell-specific promoter.
Morita A; Ariizumi K; Ritter R; Jester JV; Kumamoto T; Johnston SA; Takashima A
Gene Ther; 2001 Nov; 8(22):1729-37. PubMed ID: 11892841
[TBL] [Abstract][Full Text] [Related]
12. CD40 ligand is essential for generation of specific cytotoxic T cell responses in RNA-pulsed dendritic cell immunotherapy.
Onaitis MW; Kalady MF; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
Surgery; 2003 Aug; 134(2):300-5. PubMed ID: 12947333
[TBL] [Abstract][Full Text] [Related]
13. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
Hetttihewa LM
Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
[TBL] [Abstract][Full Text] [Related]
14. The immunology of cutaneous DNA immunization.
Tüting T
Curr Opin Mol Ther; 1999 Apr; 1(2):216-25. PubMed ID: 11715945
[TBL] [Abstract][Full Text] [Related]
15. Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes.
Grünebach F; Müller MR; Nencioni A; Brossart P
Gene Ther; 2003 Mar; 10(5):367-74. PubMed ID: 12601391
[TBL] [Abstract][Full Text] [Related]
16. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro.
Mehrotra S; Stevens R; Zengou R; Chakraborty NG; Butterfield LH; Economou JS; Dorsky DI; Mukherji B
Cancer Res; 2003 Sep; 63(17):5607-14. PubMed ID: 14500402
[TBL] [Abstract][Full Text] [Related]
17. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
18. Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis.
Dean HJ; Fuller D; Osorio JE
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):373-88. PubMed ID: 12818623
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
Kim S; Lee JB; Lee GK; Chang J
Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
[TBL] [Abstract][Full Text] [Related]
20. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.
Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J
Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]